Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Chapel

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Clinical Immunology (Orlando, Fla.)|May 19, 2001
Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis CH M Chapel, J M Christie, V Peach, et al.
BMJ (Clinical Research Ed.)|April 10, 1993
Antibody persistence after accelerated immunisation against Haemophilus influenzae type bR Booy, S Hodgson, H Griffiths, et al.
Postgraduate Medical Journal|March 1, 1991
Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemiaS A Misbah, P A Lawrence, J B Kurtz, et al.
Lancet (London, England)|August 31, 1985
Non-immunoglobin in cerebrospinal fluid of patients with Alzheimer's disease and cerebral amyloid angiopathyM M Esiri, H M Chapel, J A Morton, et al.
Journal of Immunological Methods|August 30, 1992
A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiencyJ A Faux, A E Agbarakwe, S A Misbah, et al.
Lancet (London, England)|December 1, 1979
Trial of pneumococcal vaccine for asplenic patientsP M Emerson, M P Slack, H M Chapel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous diseaseC G Mullighan, G C Fanning, H M Chapel, et al.
BMJ (Clinical Research Ed.)|August 17, 1996
Relation of C reactive protein to cardiovascular risk factors. Assays would have to be developed to measure C reactive proteinW A Sewell, A G Bird, S E Marshall, et al.
Lancet (London, England)|November 11, 1978
Immune complexes in diabetic retinopathyD H Cove, K L Woods, H M Chapel, et al.
Lancet (London, England)|April 30, 1994
Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple MyelomaH M Chapel, M Lee, R Hargreaves, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Clinical Immunology (Orlando, Fla.)|May 19, 2001
Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis CH M Chapel, J M Christie, V Peach, et al.
BMJ (Clinical Research Ed.)|April 10, 1993
Antibody persistence after accelerated immunisation against Haemophilus influenzae type bR Booy, S Hodgson, H Griffiths, et al.
Postgraduate Medical Journal|March 1, 1991
Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemiaS A Misbah, P A Lawrence, J B Kurtz, et al.
Lancet (London, England)|August 31, 1985
Non-immunoglobin in cerebrospinal fluid of patients with Alzheimer's disease and cerebral amyloid angiopathyM M Esiri, H M Chapel, J A Morton, et al.
Journal of Immunological Methods|August 30, 1992
A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiencyJ A Faux, A E Agbarakwe, S A Misbah, et al.
Lancet (London, England)|December 1, 1979
Trial of pneumococcal vaccine for asplenic patientsP M Emerson, M P Slack, H M Chapel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous diseaseC G Mullighan, G C Fanning, H M Chapel, et al.
BMJ (Clinical Research Ed.)|August 17, 1996
Relation of C reactive protein to cardiovascular risk factors. Assays would have to be developed to measure C reactive proteinW A Sewell, A G Bird, S E Marshall, et al.
Lancet (London, England)|November 11, 1978
Immune complexes in diabetic retinopathyD H Cove, K L Woods, H M Chapel, et al.
Lancet (London, England)|April 30, 1994
Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple MyelomaH M Chapel, M Lee, R Hargreaves, et al.
Pageof 9